Inogen Inc  

(Public, NASDAQ:INGN)   Watch this stock  
Find more results for INGN
-0.47 (-3.07%)
Apr 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 14.80 - 15.46
52 week 14.78 - 21.00
Open 15.37
Vol / Avg. 91,702.00/148,253.00
Mkt cap 269.49M
P/E 1,270.32
Div/yield     -
EPS 0.01
Shares 18.15M
Beta     -
Inst. own 109%

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 111.18% 33.71%
Operating margin 2.80% 5.92%
EBITD margin - 17.24%
Return on average assets 123.03% 39.14%
Return on average equity - -
Employees 354 -
CDP Score - -


326 Bollay Drive
GOLETA, CA 93117
United States - Map
+1-805-5620500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Inogen, Inc. (Inogen) is a medical technology company. The Company develops, manufactures and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It offers Inogen One systems for the patients who require long-term oxygen therapy. The Company´┐Żs products include Inogen One G3 and Inogen One G2. The Inogen One G3 and Inogen One G2, weighs at approximately 4.8 and 7.0 pounds, respectively, are amongst the most lightweight portable oxygen concentrators. It markets its product offerings, the Inogen One G3 and the Inogen One G2, as single solutions for oxygen therapy. One G2 is effective for nocturnal use. Its Inogen One G2 and the Inogen One G3 are sub-5 and sub-10 pound portable oxygen.

Officers and directors

Heath Lukatch PhD Chairman of the Board
Bio & Compensation  - Reuters
Raymond O. Huggenberger CEO, Board Member
Bio & Compensation  - Reuters